Cell wall proteins of group B Streptococcus and low incidence of neonatal disease in southern Israel

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 48, Issue 9, 2003, Pages 697-702

  Marchaim, Dror ^b   Hallak, Mordechai ^a   Gortzak Uzan, Limor ^b   Peled, Nechama ^b   Riesenberg, Klaris ^b   Schlaeffer, Francisc ^b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b NONE

Author keywords

Israel; Neonatal diseases and abnormalities; Streptococcus group B

Indexed keywords

ANTIGEN; BACTERIAL PROTEIN; CELL MEMBRANE PROTEIN; VACCINE;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL CELL WALL; BACTERIUM CULTURE; DEVELOPING COUNTRY; FEMALE; HUMAN; IMMUNE RESPONSE; INCIDENCE; INFECTION PREVENTION; ISRAEL; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN DISEASE; PREVALENCE; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS AGALACTIAE;

BACTERIAL PROTEINS; CARRIER STATE; CELL WALL; FEMALE; HUMANS; INFANT, NEWBORN; ISRAEL; PREGNANCY; PROSPECTIVE STUDIES; SEROTYPING; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 0141457758     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Glantz JC, Kedley KE: Concepts and controversies in the management of group B streptococcus during pregnancy. Birth 1998;25:45-53
2. Nitzan Y, Maayan M, Wajsman C: Streptococcus group B isolates in a regional hospital area. Med Microbiol Immunol 1980;169:21-30
3. Centers for Disease Control and Prevention: Prevention of perinatal group B streptococcal disease: A public health prospective. MMWR 1996;45:1-24
4. Lachenauer CS, Kasper DL, Shimada J, et al: Serotypes VI and VIII predominate among group B streptococci isolated from pregnant Japanese women. J Infect Dis 1999;179:1030-1033
5. Larsson C, Stalhammar-Carlemalm M, Lindahl G: Protection against experimental infection with group B streptococcus by immunization with a bivalent protein vaccine. Vaccine 1999;17:454-458
6. Kalliola S, Vuopio-Varkila J, Takala AK, et al: Neonatal GBS disease in Finland: A 10-year nationwide study. Pediatr Infect Dis J 1999;18:806-810
7. Lin FY, Clemens JD, Azimi PH, et al: Capsular polysaccharide types of group B streptococcal isolates from neonates with early-onset infection. J Infect Dis 1998;177:790-792
8. Heather EJ, Lahra MM: Eight-year outcome of universal screening and intrapartum antibiotics for maternal group B streptococcal carriers. Pediatrics 1998;101:101:e2
9. Schuchat A: Group B streptococcus. Lancet 1999;353:51-56
10. Berg S, Trollfors B, Lagergard T, et al: Serotypes and clinical manifestations of group B streptococcus infections in western Sweden. Clin Microbiol Infect 2000;6:9-13
11. Eidelman AI, Rudensky B, Turgeman D, et al: Epidemiology of group B streptococci colonization and disease in mothers and infants: Update of ongoing 10-year Jerusalem study. Isr J Med Sci 1990;26:71-73
12. Greenberg D, Shinwell ES, Yagupsky P, et al: A prospective study of neonatal sepsis and meningitis in Southern Israel. Pediatr Infect Dis J 1997;8:768-773
13. Collins TS, Calderon M, Gilman RH, et al: Group B streptococcus colonization in a developing country: Its association with sexually transmitted disease and socioeconomic factors. Am J Trop Med Hyg 1998;59:633-636
14. Strickland DM, Yeomans ER, Hankins GDV: Cost-effectiveness of intrapartum screening and treatment for maternal group B streptococci colonization. Am J Obstet Gynecol 1990;163:4-8
15. Stoll BJ, Schuchat A: Maternal carriage of group B streptococci in developing countries. Pediatr Infect Dis J 1998;17:499-503
16. Harrison LH, Elliott JA, Dwyer DM, et al: Serotype distribution of invasive group B streptococci isolates in Maryland: Implications for vaccine formulation. J Infect Dis 1998;177:998-1002
17. Elliott JA, Farmer KD, Facklam RR: Sudden increase in isolation of group B Streptococci, serotype V, is not due to emergence of a new pulsed-field gel electrophoresis type. J Clin Microbiol 1998;36:2115-2116
18. MeKenna DS, Iams JD: Group B streptococcal Infections. Semin Perinatol 1998;4:267-276